From: HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
 | <=24 | 25-34 | 35-44 | 45-54 | 55-64 | 65+ | All ages | |
---|---|---|---|---|---|---|---|---|
Histological type | ||||||||
 Squamous cell carcinoma | 16/18 (n) | 1 | 40 | 108 | 85 | 61 | 69 | 364 |
% | 100,0 | 93,0 | 76,1 | 72,6 | 72,6 | 75,0 | 76,0 | |
16/18/45 (n) | 1 | 41 | 118 | 94 | 64 | 72 | 390 | |
% | 100 | 95,3 | 83,1 | 80,3 | 76,2 | 78,3 | 81,4 | |
 | Any type (n) | 1 | 43 | 142 | 117 | 84 | 92 | 479 |
Adeno- and Adenosquamous cell carcinoma | 16/18 (n) | 0 | 5 | 15 | 5 | 10 | 8 | 43 |
% | 0 | 100 | 93,8 | 55,6 | 83,3 | 61,5 | 76,8 | |
16/18/45 (n) | 1 | 5 | 15 | 6 | 11 | 11 | 49 | |
% | 100 | 100 | 93,8 | 66,7 | 91,7 | 84,6 | 87,5 | |
 | Any type (n) | 1 | 5 | 16 | 9 | 12 | 13 | 56 |
Study | ||||||||
 Milan Study | 16/18 (n) | 0 | 25 | 65 | 44 | 38 | 15 | 187 |
% | - | 89,3 | 75,6 | 71,0 | 73,1 | 71,4 | 75,1 | |
16/18/45 (n) | 0 | 26 | 70 | 49 | 38 | 16 | 199 | |
% | - | 92,9 | 81,4 | 79,0 | 73,1 | 76,2 | 79,9 | |
 | Any type (n) | 0 | 28 | 86 | 62 | 52 | 21 | 249 |
 Rome Study | 16/18 (n) | 1 | 9 | 25 | 14 | 16 | 15 | 80 |
% | 100,0 | 100,0 | 69,4 | 60,9 | 84,2 | 62,5 | 71,4 | |
16/18/45 (n) | 1 | 9 | 28 | 17 | 16 | 15 | 86 | |
% | 100,0 | 100,0 | 77,8 | 73,9 | 84,2 | 62,5 | 76,8 | |
 | Any type (n) | 1 | 9 | 36 | 23 | 19 | 24 | 112 |
 Central and Southern Italy Study | 16/18 (n) | 0 | 11 | 33 | 32 | 17 | 47 | 140 |
% | 0,0 | 100,0 | 91,7 | 78,0 | 68,0 | 78,3 | 80,5 | |
16/18/45 (n) | 1 | 11 | 35 | 34 | 21 | 52 | 154 | |
% | 100,0 | 100,0 | 97,2 | 82,9 | 84,0 | 86,7 | 88,5 | |
 | Any type (n) | 1 | 11 | 36 | 41 | 25 | 60 | 174 |
Total | 16/18 (n) | 2 | 46 | 124 | 91 | 71 | 78 | 412 |
% | 66,7 | 93,9 | 78,0 | 71,7 | 74,0 | 73,6 | 76,3 | |
16/18/45 (n) | 3 | 47 | 134 | 101 | 75 | 84 | 444 | |
% | 100 | 95,9 | 84,3 | 79,5 | 78,1 | 79,2 | 82,2 | |
 | Any type (n) | 3 | 49 | 159 | 127 | 96 | 106 | 540 |